You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Aerosol Sargramostim
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting
  • Recurrent Metastatic Melanoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jul 29, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Recruiting
  • Brain Metastases
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Bevacizumab Injection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Melanoma Trial in United Kingdom (ATL001, Checkpoint Inhibitor)

Recruiting
  • Melanoma
  • ATL001
  • Checkpoint Inhibitor
  • Cambridge, United Kingdom
  • +6 more
Jul 23, 2021

Newly Diagnosed or Recurrent Metastatic Melanoma Patients, Malignant Brain Tumors Trial in New York (PET scan with

Active, not recruiting
  • Newly Diagnosed or Recurrent Metastatic Melanoma Patients
  • Malignant Brain Tumors
  • PET scan with 124I-cRGDY-PEG-dots
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 13, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)

Terminated
  • Unresectable, Recurrent or Metastatic Melanoma
  • Untreated Mucosal or Acral Lentiginous Melanoma
  • Beijing, Beijing, China
  • +12 more
Apr 12, 2022

Cervical Cancer, Prostate Cancer Metastatic, Breast Cancer Trial (²¹²Pb-DOTAM-GRPR1)

Recruiting
  • Cervical Cancer
  • +5 more
  • Chicago, Illinois
  • +3 more
Jan 24, 2023

Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)

Recruiting
  • Locally Advanced Unresectable or Metastatic Melanoma
  • Los Angeles, California
  • +12 more
Jun 30, 2022

SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

Not yet recruiting
  • SCLC
  • +2 more
  • GD2-SADA:177Lu-DOTA Complex
  • (no location specified)
May 4, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Complications and Recurrences After Mohs Micrographic Surgery

Recruiting
  • Skin Cancer
  • +9 more
  • Mohs surgery
  • Slow Mohs surgery
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Aug 23, 2023

Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma Trial in United States (trametinib, laboratory biomarker analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • Washington, District of Columbia
  • +3 more
May 4, 2021

Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +2 more
  • Los Angeles, California
  • +12 more
Jul 27, 2022

Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

Completed
Has Results
  • Malignant Melanoma
  • Recurrent Melanoma
  • (no location specified)
Oct 18, 2020

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +26 more
  • Biopsy
  • +5 more
  • Newark, Delaware
  • +52 more
Feb 2, 2023

AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

Recruiting
  • AIDS-Related Non-Hodgkin Lymphoma
  • +29 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Birmingham, Alabama
  • +12 more
Aug 4, 2022